Search for: "PHARMA INVESTMENT LTD." Results 41 - 60 of 63
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 May 2008, 9:09 am
– Brdo: (IPR-Helpdesk), 5-6 June: USFDA public meeting on evaluation of product trade names: (FDA Law Blog), 5-7 June: European research and innovation exhibition – Paris: (IPR-Helpdesk), 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with… [read post]
3 Jun 2016, 6:40 am by Dennis Crouch
MPHJ Technology Investments, LLC, No. 15-838 (Federal court jurisdiction in anti-troll consumer protection case) Daiichi Sankyo Company, Ltd. v. [read post]
15 Dec 2014, 7:25 am
.* Hurray for judicial sense on product by process claims- Birss triumphs in Hospira v GenentechThis note from Darren is about Hospira v Genentech [on which see the IPKat note here], a pharma-patent case that Mr Justice Birss has decided in light of product-by-process claims. [read post]
16 Jun 2019, 11:07 am
DesignsRosie Burbidge published her last post as an official GuestKat, providing a tour of some recent design decisions, including Tynan v J4K Sports Ltd [2018] EWHC 3519 and Pulseon OY v Garmin (Europe) Ltd [2019] EWCA Civ 138. [read post]
13 Jun 2019, 1:06 pm
A soft IP storybook on the Byzantine World of Trade Marks with Benet Brandreth | Fordham 27 Recap: Reports 1-14 | European Pharma Law Academy returns to Cambridge | New joint IPKat/BLACA event on 'The EU DSM Directive: End of the Story? [read post]
28 Mar 2008, 6:00 am
- Anonymity of policy research group quoted on pharma patenting policy and stats: (Spicy IP),Thailand: More news/reactions on compulsory licenses: (Generic Pharmaceuticals & IP),US: Follow-on biologic drugs and patent law: A potential disconnect? [read post]
1 Apr 2016, 8:22 am by Dennis Crouch
Flexible Obviousness Test Does Not Apply to Secondary Indicia of Nonobviousness: In Cubist Pharma v. [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
6 Jul 2009, 8:48 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: EPO sets deadline for presidential applications; Jesper Kongstad, Benoît Battistelli enter the fray in battle to be next EPO President (Managing Intellectual Property) (IAM) (IAM) ECJ: Dutch brewer allowed to use Italian BAVARIA trade marks despite ‘Bayerisches Bier’ (Bavarian Beer) PGI: Bavaria NV and Bavaria… [read post]
11 Jul 2008, 4:30 am
: (Spicy IP), India: Ranbaxy-Daiichi deal – Opportunities for private equity companies in India: (Profitability through Simplicity), India: (KEI) Cracking open anti-competitive practices in the developing world: complaints, amendments and waivers: (Spicy IP), India: Is it one rule for Indian pharma companies and another one for those from abroad? [read post]
9 May 2008, 10:30 pm
: (Ezine @rticles) Global - Patents Rise of machine translation services: (IPKat), USPTO / EPO / JPO progress on ‘common application format’ for expedited examination: (Peter Zura's 271 Patent Blog), Proponents: ‘Time is now’ for TRIPs biodiversity amendment in Doha round: (Intellectual Property Watch), TRIPs amendment in favour of disclosures for genetic resources/traditional knowledge patents gathers support: (Afro-IP), WIPO… [read post]
6 Jun 2008, 6:49 am
: (Spicy IP)   Events 9-12 June: (US) Strategies for management of IP – Chicago: (IPR-Helpdesk), 11 June: US PLI ‘Advanced patent licensing 2008: What you need to know before licensing your patent’ – San Francisco: (Patent Docs), 11 June: MARQUES ‘First meeting with Spanish Judges of the Community Trade Mark Courts’ – Alicante: (Class 46), 13-14 June: Centre for European Economic Research conference on ‘The… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
19 Sep 2008, 6:00 pm
: (Spicy IP), India: Supreme Court on exclusive marketing rights: (Spicy IP), Japan: First induced pluripotent stem (iPS) cell patent at Kyoto University: (Competitive Info), Slovenia: Supplementary protection certificates in Slovenia: (The SPC Blog), United States: Biotech/pharma lobbying scoreboard – second quarter update – part II: (Patent Docs), United States: Ferring Pharmaceuticals argues to bring down direct purchaser suits: (Law 360), United States: Transferred… [read post]
1 Feb 2008, 12:00 am
: Industries Ltd v Dynamic Supply Pty Ltd: (IP Down Under)BrazilIFPI raids hundreds of internet cafes: 600 cops, one arrest: (Ars Technica)CanadaInterlocutory injunctions in trade mark cases: a difficult test to meet: CMAC Mortgages v Canadian Mortgage Expert Centre and CanadaHyundai Autov Cross Canada Auto Body Supply: (Canadian Trademark Blog), (coverage of Hyundia - IPblog), Privacy Coalition warns on copyright reform: (Michael Geist),Wikinomics on… [read post]
19 Apr 2022, 8:05 am by Mridu Katoch
Of these three entities, universities have continued to invest in patents and acquired a significant share of worldwide publications. [read post]
19 Jul 2022, 2:59 pm by Kevin LaCroix
In the following guest post, the authors revisit the question of whether or not securities class action lawsuits against development-stage biotech companies are likelier to survive a motion to dismiss compared to securities suits against other kinds of companies. [read post]